• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国安全网中经皮冠状动脉介入治疗的住院治疗结果:来自 NCDR Cath-PCI 登记处的见解。

In-Hospital Outcomes of Percutaneous Coronary Intervention in America's Safety Net: Insights From the NCDR Cath-PCI Registry.

机构信息

University of California, San Francisco, Fresno, California.

Saint Luke's Mid-America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri.

出版信息

JACC Cardiovasc Interv. 2017 Aug 14;10(15):1475-1485. doi: 10.1016/j.jcin.2017.05.042.

DOI:10.1016/j.jcin.2017.05.042
PMID:28797422
Abstract

OBJECTIVES

This study compared risk-adjusted percutaneous coronary intervention (PCI) outcomes of safety-net hospitals (SNHs) and non-SNHs.

BACKGROUND

Although risk adjustment is used to compare hospitals, SNHs treat a disproportionate share of uninsured and underinsured patients, who may have unmeasured risk factors, limited health care access, and poorer outcomes than patients treated at non-SNHs.

METHODS

Using the National Cardiovascular Data Registry CathPCI Registry from 2009 to 2015, we analyzed 3,746,961 patients who underwent PCI at 282 SNHs (hospitals where ≥10% of PCI patients were uninsured) and 1,134 non-SNHs. The relationship between SNH status and risk-adjusted outcomes was assessed.

RESULTS

SNHs were more likely to be lower volume, rural hospitals located in the southern states. Patients treated at SNHs were younger (63 vs. 65 years), more often nonwhite (17% vs. 12%), smokers (33% vs. 26%), and more likely to be admitted through the emergency department (48% vs. 38%) and to have an ST-segment elevation myocardial infarction (20% vs. 14%) than non-SNHs (all p < 0.001). Patients undergoing PCI at SNHs had higher risk-adjusted in-hospital mortality (odds ratio: 1.23; 95% confidence interval: 1.17 to 1.32; p < 0.001), although the absolute risk difference between groups was small (0.4%). Risk-adjusted bleeding (odds ratio: 1.05; 95% confidence interval: 1.00 to 1.12; p = 0.062) and acute kidney injury rates (odds ratio: 1.01; 95% confidence interval: 0.96 to 1.07; p = 0.51) were similar.

CONCLUSIONS

Despite treating a higher proportion of uninsured patients with more acute presentations, risk-adjusted PCI-related in-hospital mortality of SNHs is only marginally higher (4 additional deaths per 1,000 PCI cases) than non-SNHs, whereas risk-adjusted bleeding and acute kidney injury rates are comparable.

摘要

目的

本研究比较了安全网医院(SNH)和非 SNH 的经皮冠状动脉介入治疗(PCI)风险调整结局。

背景

尽管风险调整用于比较医院,但 SNH 治疗的无保险和保险不足的患者比例不成比例,这些患者可能存在未测量的风险因素、有限的医疗保健机会和比非 SNH 治疗的患者更差的结局。

方法

使用 2009 年至 2015 年国家心血管数据登记处 CathPCI 登记处,我们分析了在 282 家 SNH(接受 PCI 的患者中≥10%无保险)和 1134 家非 SNH 接受 PCI 的 3746961 名患者。评估 SNH 状态与风险调整结局之间的关系。

结果

SNH 更可能是较低容量、位于南部各州的农村医院。在 SNH 接受治疗的患者年龄更小(63 岁 vs. 65 岁),非白人(17% vs. 12%)、吸烟者(33% vs. 26%)的比例更高,更有可能通过急诊就诊(48% vs. 38%),且更有可能患有 ST 段抬高型心肌梗死(20% vs. 14%),而非 SNH(所有 p<0.001)。在 SNH 接受 PCI 的患者的风险调整院内死亡率较高(优势比:1.23;95%置信区间:1.17 至 1.32;p<0.001),尽管两组之间的绝对风险差异较小(0.4%)。风险调整后的出血(优势比:1.05;95%置信区间:1.00 至 1.12;p=0.062)和急性肾损伤发生率(优势比:1.01;95%置信区间:0.96 至 1.07;p=0.51)相似。

结论

尽管 SNH 治疗的无保险患者比例更高,且临床表现更急性,但风险调整后的 PCI 相关院内死亡率仅略高于非 SNH(每 1000 例 PCI 病例增加 4 例死亡),而风险调整后的出血和急性肾损伤发生率相似。

相似文献

1
In-Hospital Outcomes of Percutaneous Coronary Intervention in America's Safety Net: Insights From the NCDR Cath-PCI Registry.美国安全网中经皮冠状动脉介入治疗的住院治疗结果:来自 NCDR Cath-PCI 登记处的见解。
JACC Cardiovasc Interv. 2017 Aug 14;10(15):1475-1485. doi: 10.1016/j.jcin.2017.05.042.
2
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.接受经皮冠状动脉介入治疗患者急性肾损伤的当代发病率、预测因素及预后:来自国家心血管数据注册库(NCDR)导管介入治疗注册研究的见解
JACC Cardiovasc Interv. 2014 Jan;7(1):1-9. doi: 10.1016/j.jcin.2013.06.016.
3
The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry.《从全国心血管数据注册中心经皮冠状动脉介入治疗(PCI)注册研究看出血预防策略对经皮冠状动脉介入治疗术后出血率的医院间差异的影响》
JACC Cardiovasc Interv. 2016 Apr 25;9(8):771-779. doi: 10.1016/j.jcin.2016.01.033.
4
In-Hospital Outcomes of ST-Segment Elevation Myocardial Infarction Complicated With Cardiogenic Shock at Safety-Net Hospitals in the United States (from the Nationwide Inpatient Sample).美国安全网医院 ST 段抬高型心肌梗死合并心原性休克患者的住院治疗结果(来自全国住院患者样本)。
Am J Cardiol. 2019 Aug 15;124(4):485-490. doi: 10.1016/j.amjcard.2019.05.037. Epub 2019 May 28.
5
Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.经桡动脉入路应用比伐卢定抗凝与肝素进行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的结局:来自全国心血管数据注册中心的报告。
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1102-1111. doi: 10.1016/j.jcin.2017.03.021. Epub 2017 May 17.
6
Trends and Outcomes After Same-Day Discharge After Percutaneous Coronary Interventions.经皮冠状动脉介入治疗后当日出院的趋势及结果
Circ Cardiovasc Qual Outcomes. 2017 Aug;10(8). doi: 10.1161/CIRCOUTCOMES.117.003936.
7
Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry.急性心肌梗死合并心源性休克患者接受经皮冠状动脉介入治疗的时间趋势和结局:来自心脏导管介入注册研究的报告
JACC Cardiovasc Interv. 2016 Feb 22;9(4):341-351. doi: 10.1016/j.jcin.2015.10.039. Epub 2016 Jan 20.
8
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).伴有非ST段抬高型心肌梗死的糖尿病合并多支冠状动脉疾病患者的血运重建趋势:来自国家心血管数据注册库急性冠状动脉治疗和干预结果网络注册库-遵循指南行动(NCDR ACTION注册库-GWTG)的见解
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
9
Impact of Glycoprotein IIb/IIIa Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the National Cardiovascular Data Registry.急性冠状动脉综合征患者行经皮冠状动脉介入治疗时应用糖蛋白Ⅱb/Ⅲa 抑制剂的影响:来自国家心血管数据登记处的见解。
JACC Cardiovasc Interv. 2015 Oct;8(12):1574-82. doi: 10.1016/j.jcin.2015.04.031.
10
Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States.美国顶尖医院和非顶尖医院行经皮冠状动脉介入治疗的适宜性和结局。
JACC Cardiovasc Interv. 2018 Feb 26;11(4):342-350. doi: 10.1016/j.jcin.2017.10.042. Epub 2017 Nov 12.

引用本文的文献

1
Racial Disparities and Outcomes of Percutaneous Coronary Interventions in Patients Above 65 Years in America: A Systematic Review.美国65岁以上患者经皮冠状动脉介入治疗的种族差异与预后:一项系统评价
Cureus. 2023 Jul 25;15(7):e42457. doi: 10.7759/cureus.42457. eCollection 2023 Jul.
2
Trends in the likelihood of receiving percutaneous coronary intervention in a low-volume hospital and disparities by sociodemographic communities.低容量医院接受经皮冠状动脉介入治疗的可能性趋势及社会人口统计学社区的差异。
PLoS One. 2023 Jan 18;18(1):e0279905. doi: 10.1371/journal.pone.0279905. eCollection 2023.
3
Processes of care and outcomes for homeless patients hospitalised for cardiovascular conditions at safety-net versus non-safety-net hospitals: cross-sectional study.
为心血管疾病住院的无家可归患者在保障性和非保障性医院的护理流程和结果:横断面研究。
BMJ Open. 2021 Apr 8;11(4):e046959. doi: 10.1136/bmjopen-2020-046959.
4
Impact of a telemedicine-guided, population-based, STEMI network on reperfusion strategy, efficiency, and outcomes: Impact of telemedicine on STEMI management.远程医疗指导的基于人群的ST段抬高型心肌梗死网络对再灌注策略、效率及结局的影响:远程医疗对ST段抬高型心肌梗死管理的影响
AsiaIntervention. 2021 Jul;7(1):18-26. doi: 10.4244/AIJ-D-18-00047.
5
Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015.2013 年至 2015 年美国退伍军人事务部医院中稳定型冠心病患者经皮冠状动脉介入治疗的适宜性。
JAMA Netw Open. 2020 Apr 1;3(4):e203144. doi: 10.1001/jamanetworkopen.2020.3144.
6
Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.既往缺血性卒中和出血性卒中患者行经皮冠状动脉介入治疗后的缺血和出血风险。
J Am Heart Assoc. 2019 Nov 19;8(22):e013356. doi: 10.1161/JAHA.119.013356. Epub 2019 Nov 8.
7
Outcomes of acute coronary syndrome patients with concurrent extra-cardiac vascular disease in the era of transradial coronary intervention: A retrospective multicenter cohort study.经桡动脉入路冠状动脉介入治疗时代合并心脏外血管疾病的急性冠状动脉综合征患者的结局:一项回顾性多中心队列研究。
PLoS One. 2019 Oct 16;14(10):e0223215. doi: 10.1371/journal.pone.0223215. eCollection 2019.
8
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.定义经皮冠状动脉介入治疗患者的高出血风险:来自高出血风险学术研究联合会的共识文件。
Eur Heart J. 2019 Aug 14;40(31):2632-2653. doi: 10.1093/eurheartj/ehz372.
9
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.定义行经皮冠状动脉介入治疗患者的高出血风险。
Circulation. 2019 Jul 16;140(3):240-261. doi: 10.1161/CIRCULATIONAHA.119.040167. Epub 2019 May 22.